Replies to post #236223 on Biotech Values

[DewDiligence]

ANCN +250% on no news I’m aware of.

[DewDiligence]

ANCN—>CMMB following 1:4 reverse split, pursuant to previously announced reverse-merger:

https://www.prnewswire.com/news-releases/chemomab-completes-merger-with-anchiano-therapeutics-301248816.html

The company also raised $45.5M in a private placement.